Table 1.
Pathogen | Locus/Gene | Function | Infection model | Phenotype of mutant during infection, relative to wild-type |
Reference |
---|---|---|---|---|---|
Transportation | |||||
M. tuberculosis | mctB | Mycomembrane channel; efflux | Inhalational; guinea pig | Reduced bacterial burdens in lungs and lymph nodes | [63] |
ctpV | Putative inner membrane protein; efflux | Inhalational; mouse, guinea pig | Reduced lung damage and immune response, decreased mortality of mice | [64] | |
ricR | Transcriptional repressor of Cu responsive regulon; Cu homeostasis | Inhalational; mouse | Mutant with constitutive repression of ricR regulon has reduced bacterial burden in lungs | [65] | |
S. Typhimurium | copA and golT | Inner membrane P1B-type ATPases; efflux | Peritoneal macrophages | Decreased survival of ΔcopA ΔgolTin wildtype but not ATP7aLysMcre macrophages | [27] |
RAW264.7 macrophages | Decreased survival of ΔcopA ΔgolT | [48] | |||
Competitive intraperitoneal challenge; mouse | Decreased survival of ΔcopA ΔgolT in livers and spleens | [27] | |||
*E. coli | copA | Inner membrane P1B− type ATPase; efflux | RAW264.7 macrophages | Decreased survival of mutant | [26] |
S. pneumoniae | copA | Inner membrane P1B− type ATPase; efflux | Intratracheal, intraperitoneal, and intravenous; mouse | Decreased survival in blood, decreased mortality of mice | [49,66] |
A549 lung epithelial cells | Decreased adherence and invasion | [49] | |||
Sequestration | |||||
Uropathogenic E. coli | ybt | Cu-binding siderophore (yersiniabactin); sequestration, detoxification | Urinary tract infection; mouse and human | Uropathogenic E. coli expressing ybt during infection has enhanced Cu resistance Cu(II)-Ybt forms during infection | [45] |
RAW264.7 macrophages | Decreased survival of mutant in Cu-replete macrophages | [47] | |||
Oxidation | |||||
S. Typhimurium | cueO | Multicopper oxidase; detoxification | Oral gavage; mouse | Decreased burdens in liver and spleen | [67] |
Non-pathogenic, but provided as a model Gram-negative organism.